A PHASE I, MULTICENTER, OPEN-LABEL,UNCONTROLLED STUDY TO EVALUATE PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY, AND TOLERABILITY OFSATRALIZUMAB IN ADULT PATIENTS WITH AQP4 ANTIBODYPOSITIVE NEUROMYELITIS OPTICA SPECTRUM DISORDER WITH BODYWEIGHT 100 KG
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/brain-nervous.jpg)
Details
Age
Adult
Locations
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
![Photograph of Jeffrey Bennett](https://som.ucdenver.edu/FIMS/Content/faculty/3730/CU-Doctors-3730.jpg)
Jeffrey Bennett
Study ID
Protocol Number: 22-1981
More information available at ClinicalTrials.gov: NCT00000000
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers